MARC

LEADER 00000cam a2200000Ia 4500
001 EBSCO_ocm57005524
003 OCoLC
005 20231017213018.0
006 m o d
007 cr cnu|||unuuu
008 041120s2001 dcuad ob 000 0 eng d
010 |z  2002277341 
040 |a N$T  |b eng  |e pn  |c N$T  |d OCLCQ  |d YDXCP  |d OCLCQ  |d MMU  |d BAKER  |d LVB  |d REDDC  |d OCLCE  |d OCLCQ  |d IDEBK  |d COF  |d OCLCQ  |d MERUC  |d CCO  |d E7B  |d GPM  |d DKDLA  |d NNM  |d SNM  |d OCLCQ  |d XFF  |d FVL  |d OCLCQ  |d OCLCO  |d OCLCQ  |d NLGGC  |d OCLCQ  |d UV0  |d EBLCP  |d OCLCQ  |d AZK  |d LOA  |d OCLCO  |d OCLCA  |d TOA  |d OCLCO  |d MOR  |d PIFBR  |d ZCU  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCQ  |d OCLCO  |d NJR  |d OCLCA  |d AGLDB  |d OCLCA  |d U3W  |d BUF  |d OCLCO  |d OCLCQ  |d OCLCO  |d OCLCF  |d OCLCO  |d STF  |d VNS  |d WRM  |d OCLCO  |d OCLCQ  |d VTS  |d OCLCO  |d COCUF  |d NRAMU  |d EZ9  |d ICG  |d VT2  |d AU@  |d OCLCQ  |d OCLCO  |d WYU  |d OCLCA  |d G3B  |d DKC  |d OCLCO  |d OCLCQ  |d OCLCO  |d MERER  |d OCLCO  |d CEF  |d OCLCQ  |d OCLCO  |d ADU  |d KIJ  |d OCLCQ  |d K6U  |d OCLCA  |d UKCRE  |d OCLCO  |d OCLCQ  |d OCL  |d OCLCO 
015 |a GBA376785  |2 bnb 
015 |a GBA3-76785 
019 |a 48972074  |a 49604899  |a 70752236  |a 475754481  |a 488338610  |a 559521597  |a 606676038  |a 609216218  |a 646723489  |a 666925644  |a 722312199  |a 728011803  |a 756529205  |a 767450788  |a 771300093  |a 923268733  |a 961559357  |a 962587840  |a 966261309  |a 988482525  |a 991915290  |a 1011897732  |a 1017612098  |a 1018027318  |a 1028767577  |a 1037900777  |a 1038185333  |a 1038668518  |a 1044634997  |a 1045387444  |a 1045485320  |a 1047574288  |a 1055377160  |a 1065042781  |a 1103541314  |a 1112872373  |a 1119150538  |a 1119441577  |a 1153535487  |a 1204384453  |a 1228582382 
020 |a 0309565731  |q (electronic bk.) 
020 |a 9780309565738  |q (electronic bk.) 
020 |z 0309076366 
020 |z 9780309076364 
020 |z 0309090083  |q (pbk.) 
020 |z 9780309090087  |q (pbk.) 
029 1 |a DEBBG  |b BV043097210 
029 1 |a DEBBG  |b BV044107824 
029 1 |a DEBSZ  |b 422355895 
029 1 |a GBVCP  |b 801216311 
029 1 |a NZ1  |b 12018854 
029 1 |a NZ1  |b 16068044 
029 1 |a DKDLA  |b 820120-katalog:999943110505765 
035 |a (OCoLC)57005524  |z (OCoLC)48972074  |z (OCoLC)49604899  |z (OCoLC)70752236  |z (OCoLC)475754481  |z (OCoLC)488338610  |z (OCoLC)559521597  |z (OCoLC)606676038  |z (OCoLC)609216218  |z (OCoLC)646723489  |z (OCoLC)666925644  |z (OCoLC)722312199  |z (OCoLC)728011803  |z (OCoLC)756529205  |z (OCoLC)767450788  |z (OCoLC)771300093  |z (OCoLC)923268733  |z (OCoLC)961559357  |z (OCoLC)962587840  |z (OCoLC)966261309  |z (OCoLC)988482525  |z (OCoLC)991915290  |z (OCoLC)1011897732  |z (OCoLC)1017612098  |z (OCoLC)1018027318  |z (OCoLC)1028767577  |z (OCoLC)1037900777  |z (OCoLC)1038185333  |z (OCoLC)1038668518  |z (OCoLC)1044634997  |z (OCoLC)1045387444  |z (OCoLC)1045485320  |z (OCoLC)1047574288  |z (OCoLC)1055377160  |z (OCoLC)1065042781  |z (OCoLC)1103541314  |z (OCoLC)1112872373  |z (OCoLC)1119150538  |z (OCoLC)1119441577  |z (OCoLC)1153535487  |z (OCoLC)1204384453  |z (OCoLC)1228582382 
037 |n Title subscribed to via ProQuest Academic Complete 
042 |a dlr 
050 4 |a RA638  |b .I648 2001eb 
060 4 |a 2001 O-342 
060 4 |a WS 135  |b I333 2001 
072 7 |a MED  |x 076000  |2 bisacsh 
072 7 |a MED  |x 030000  |2 bisacsh 
072 7 |a MED  |x 078000  |2 bisacsh 
082 0 4 |a 614.5/98  |2 22 
049 |a UAMI 
245 0 0 |a Immunization safety review :  |b thimerosal-containing vaccines and neurodevelopmental disorders /  |c Kathleen Stratton, Alicia Gable, and Marie C. McCormick, editors ; Immunization Safety Review Committee, Board on Health Promotion and Disease Prevention, Institute of Medicine. 
246 3 0 |a Thimerosal-containing vaccines and neurodevelopmental disorders 
260 |a Washington, D.C. :  |b National Academy Press,  |c ©2001. 
300 |a 1 online resource (xiii, 122 pages) :  |b illustrations, charts 
336 |a text  |b txt  |2 rdacontent 
337 |a computer  |b c  |2 rdamedia 
338 |a online resource  |b cr  |2 rdacarrier 
347 |a data file  |2 rda 
490 1 |a The compass series 
504 |a Includes bibliographical references. 
588 0 |a Print version record. 
506 |3 Use copy  |f Restrictions unspecified  |2 star  |5 MiAaHDL 
533 |a Electronic reproduction.  |b [Place of publication not identified] :  |c HathiTrust Digital Library,  |d 2010.  |5 MiAaHDL 
538 |a Master and use copy. Digital master created according to Benchmark for Faithful Digital Reproductions of Monographs and Serials, Version 1. Digital Library Federation, December 2002.  |u http://purl.oclc.org/DLF/benchrepro0212  |5 MiAaHDL 
583 1 |a digitized  |c 2010  |h HathiTrust Digital Library  |l committed to preserve  |2 pda  |5 MiAaHDL 
505 0 |a ""IMMUNIZATION SAFETY REVIEW""; ""Copyright""; ""Acknowledgments""; ""Contents""; ""Executive Summary""; ""PLAUSIBILITY ASSESSMENT""; ""Biological Plausibility""; ""Causality""; ""SIGNIFICANCE ASSESSMENT""; ""PUBLIC HEALTH RESPONSE""; ""Policy Review and Analysis""; ""Public Health and Biomedical Research""; ""Epidemiological Research""; ""Clinical Research""; ""Basic Science Research""; ""Communications""; ""SUMMARY""; ""REFERENCES""; ""Immunization Safety Review: Thimerosal-Containing Vaccines and Neurodevelopmental Disorders ""; ""ORIGINS OF THE IMMUNIZATION SAFETY REVIEW PROJECT"" 
505 8 |a ""THE CHARGE TO THE COMMITTEE""""THE STUDY PROCESS""; ""THE FRAMEWORK FOR ASSESSING CAUSALITY""; ""UNDER REVIEW: THIMEROSAL-CONTAINING VACCINES AND NEURODEVELOPMENTAL DISORDERS""; ""Thimerosal in Vaccines""; ""Neurodevelopmental Disorders""; ""Autism""; ""Attention Deficit/Hyperactivity Disorder (ADHD)""; ""Speech or Language Delay""; ""PLAUSIBILITY ASSESSMENT""; ""Evidence Regarding Association: Biological Plausibility""; ""Mercury Toxicokinetics""; ""Comparisons of Ethylmercury and Methylmercury""; ""Health Effects of High-Dose Exposures to Thimerosal, Ethylmercury, and Methylmercury"" 
505 8 |a ""Health Effects of Low-Dose Exposures to Thimerosal and Methylmercury""""Investigations Related to Mercury and Heavy Metals in Children with Autism""; ""Application of Methylmercury Exposure Guidelines to Thimerosal Exposure from Vaccines""; ""Biological Plausibility Argument""; ""Evidence Regarding Association: Case Reports, Case Series, and Uncontrolled and Controlled Epidemiological Studies""; ""Case Reports and Case Series""; ""Epidemiological Studies""; ""CAUSALITY ARGUMENT""; ""SIGNIFICANCE ASSESSMENT""; ""Concern Regarding Neurodevelopmental Disorders"" 
505 8 |a ""Continued Exposure to Thimerosal""""Use of Thimerosal-Containing Vaccines in Other Countries""; ""Confusion from Changes in Hepatitis B Immunization Policy""; ""Trust in the Safety of Vaccines""; ""Conclusion""; ""RECOMMENDATIONS REGARDING THE PUBLIC HEALTH RESPONSE""; ""Policy Review and Analysis""; ""Public Health and Biomedical Research""; ""Epidemiological Studies""; ""Clinical Studies""; ""Basic Science Studies""; ""Communications""; ""SUMMARY""; ""REFERENCES""; ""Appendix A Immunization Safety Review: Measles-Mumps-Rubella Vaccine and Autism Executive Summary "" 
505 8 |a ""OVERVIEW OF THE IMMUNIZATION SAFETY REVIEW PROJECT""""THE HYPOTHESIZED RELATIONSHIP BETWEEN MMR AND AUTISM""; ""PLAUSIBILITY ASSESSMENT""; ""SIGNIFICANCE ASSESSMENT""; ""RECOMMENDATIONS""; ""Public Health Response""; ""Policy Review""; ""Research Regarding MMR and ASD""; ""Communications""; ""General and Crosscutting Issues""; ""SUMMARY""; ""REFERENCES""; ""Appendix B Monday, July 16, 2001 Meeting Agenda ""; ""Appendix C Thimerosal Content in Licensed Vaccines ""; ""Appendix D Immunization Safety Review Committee Biosketches ""; ""Board on Health Promotion Disease Prevention Liaison"" 
590 |a eBooks on EBSCOhost  |b EBSCO eBook Subscription Academic Collection - Worldwide 
650 0 |a Vaccination  |x Complications. 
650 0 |a Developmental disabilities  |x Etiology. 
650 0 |a Organomercury compounds  |x Physiological effect. 
650 0 |a Children. 
650 0 |a Immunization. 
650 2 |a Vaccination  |x adverse effects 
650 2 |a Vaccines  |x adverse effects 
650 2 |a Neurotoxicity Syndromes  |x etiology 
650 2 |a Thimerosal  |x toxicity 
650 2 |a Child 
650 2 |a Child Development Disorders, Pervasive  |x etiology 
650 2 |a Thimerosal  |x adverse effects 
650 2 |a Immunization 
650 2 |a Safety 
650 2 |a Autistic Disorder  |x etiology 
650 6 |a Vaccination  |x Complications et séquelles. 
650 6 |a Thiomersal  |x Effets physiologiques. 
650 6 |a Troubles du développement  |x Étiologie. 
650 6 |a Composés organomercuriques  |x Effets physiologiques. 
650 6 |a Enfants. 
650 6 |a Immunisation. 
650 7 |a children (people by age group)  |2 aat 
650 7 |a MEDICAL.  |2 bisac 
650 7 |a Immunology.  |2 bisac 
650 7 |a MEDICAL  |x Preventive Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Forensic Medicine.  |2 bisacsh 
650 7 |a MEDICAL  |x Public Health.  |2 bisacsh 
650 7 |a Immunization  |2 fast 
650 7 |a Children  |2 fast 
650 7 |a Developmental disabilities  |x Etiology  |2 fast 
650 7 |a Vaccination  |x Complications  |2 fast 
653 |a Andre fag (naturvidenskab og teknik)  |a Andre fag 
700 1 |a Stratton, Kathleen R. 
700 1 |a Gable, Alicia. 
700 1 |a McCormick, Marie C. 
710 2 |a Institute of Medicine (U.S.).  |b Immunization Safety Review Committee. 
776 0 8 |i Print version:  |t Immunization safety review.  |d Washington, D.C. : National Academy Press, ©2001  |z 0309076366  |w (DLC) 2002277341  |w (OCoLC)48633600 
830 0 |a Compass series (Washington, D.C.) 
856 4 0 |u https://ebsco.uam.elogim.com/login.aspx?direct=true&scope=site&db=nlebk&AN=121308  |z Texto completo 
938 |a Baker & Taylor  |b BKTY  |c 30.75  |d 30.75  |i 0309076366  |n 0004018107  |s active 
938 |a ProQuest Ebook Central  |b EBLB  |n EBL3377165 
938 |a ebrary  |b EBRY  |n ebr10068398 
938 |a EBSCOhost  |b EBSC  |n 121308 
938 |a ProQuest MyiLibrary Digital eBook Collection  |b IDEB  |n 18418 
938 |a YBP Library Services  |b YANK  |n 2293643 
994 |a 92  |b IZTAP